Thompson Davis & Co., Inc. Albireo Pharma, Inc. Transaction History

Thompson Davis & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$21.19 - $31.29 $26,741 - $39,487	-1,262 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$29.29 - $36.87 $3,661 - $4,608	-125 Reduced 9.01%	1,262 $42,000
Q2 2018 Aug 03, 2018	SELL	$28.9 - $37.31 $3,612 - $4,663	-125 Reduced 8.27%	1,387 $49,000
Q1 2018 May 02, 2018	BUY	$26.78 - $39.35 $34,599 - $50,840	1,292 Added 587.27%	1,512 $49,000
Q4 2017 Feb 05, 2018	BUY	$21.56 - $28.14 $4,743 - $6,190	220	220 $6,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.